Literature DB >> 20464581

Hypertension as a risk factor for migraine chronification.

P Barbanti1, C Aurilia, G Egeo, L Fofi.   

Abstract

Progression of episodic migraine to chronic migraine may be related to comorbid medical conditions. In this study, we focused on the role played by arterial hypertension in migraine transformation. Several studies reveal that hypertension is associated with chronic migraine and may induce migraine chronification. Hypertension probably amplifies the effects of migraine on the vascular wall further enhancing the endothelial dysfunction in cerebral vasculature. Consequently, monitoring of blood pressure is recommended in migraineurs showing an otherwise unexplained increase in attack frequency. Studies are needed to verify if prophylactic treatment with drugs improving endothelial function (e.g. calcium channel blockers, beta blockers, calcium inhibitors, ACE inhibitors and sartans) may selectively ameliorate the course of migraine in these patients.

Entities:  

Mesh:

Year:  2010        PMID: 20464581     DOI: 10.1007/s10072-010-0269-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review.

Authors:  Hugo Sevivas; Paula Fresco
Journal:  Eur J Med Res       Date:  2022-06-04       Impact factor: 4.981

Review 2.  Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.

Authors:  V Tullo; G Bussone; S Omboni; P Barbanti; P Cortelli; M Curone; C Peccarisi; C Benedetto; D Pezzola; D Zava; G Allais
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

3.  The relationship between resting arterial blood pressure and acute postoperative pain in endodontic patients.

Authors:  James Wayne King; Eric Bair; Derek Duggan; William Maixner; Asma A Khan
Journal:  J Orofac Pain       Date:  2012

4.  A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns.

Authors:  David J Muzina; William Chen; Steven J Bowlin
Journal:  Neuropsychiatr Dis Treat       Date:  2011-11-11       Impact factor: 2.570

5.  Elevated blood pressure and analgesic overuse in chronic daily headache: an outpatient clinic-based study from China.

Authors:  Qingqing Huang; Wangwen Li; Nan Li; Jing Wang; Ge Tan; Lixue Chen; Guangcheng Qin; Xiping Liang; Jiying Zhou
Journal:  J Headache Pain       Date:  2013-06-17       Impact factor: 7.277

6.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

Review 7.  Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Authors:  Gianni Allais; Chiara Benedetto
Journal:  Drug Des Devel Ther       Date:  2016-10-03       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.